Clinical trial
Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant…
NCT00336895 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00336895 |
|---|---|
| Title | Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients |
| Official title | Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Immunosuppression |
| Intervention type | Drug |
| Interventions | Myfortic |
| Enrollment | 29 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 14, 2006 |
| Last update posted | Nov 7, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: